Summary
Background A well established drug for the treatment of asthma and allergy, sodium cromoglycale, was found in open trials to be useful as a symptomalic treatment for upper respiratory tract infections.
Objective To compare the efficacy of inhaled and intranasal sodium cromoglyeate and matching placebos on the symptoms of upper respiratory tract infections.
Methods Adult subjects with symptoms of runny nose, throat pain, or cough for less than 24 h were recruited. They were treated for 7 days using a randomized, double‐blind, placebo‐controlled, group comparative design. The medication given was: sodium cromoglyeate dry powder 20mg per inhalation in spincaps; sodium cromoglycate aqueous nasal spray delivering 5.2mg per dose; or matching placebo as dry powder and nasal spray. One spincap and one spray per nostril were taken every 2h during waking hours on days 1 and 2 and then four times daily on days 3–7. Severity of nine symptoms (general malaise, body aches and pains, chills and shivering, snzeening, nasal running, nasal blocking, sore throat, cough and voice disturbance) was recorded twice daily by subjects on diary cards, using a scale of 0 (absent) to 3 (severe).
Results The sludy was conducted between February and April 1993. One hundred and eighteen patients aged 21–63 years (mean 41 years) were included. Symptoms resolved faster (P < 0.001) and the severity in the last three days of treatment was significantly less in patients treated with sodium cromoglycate than with placebo (P < 0.05‐day 5; P < 0.01‐day 6; P < 0.001‐day 7). Side‐effects were local and mild and did not differ between the treatment groups.
Conclusion Sodium cromoglyeate administered both by inhalation and intranasally is an effective treatment for the symptoms of upper respiratory tract infection. Its combined safety and efficacy would make it an acceptable form of treatment for these conditions.
Keywords: upper respiratory tract infections, drug therapy, adults, sodium cromoglyeate
References
- 1. Beare AS, Reed SE. The study of antiviral compounds in volunteers In Oxford JS, ed. Chemoprophylaxis and viral infections of the respiratory tract. Vol II Cleveland : CRC Press, 1977: 27–55. [Google Scholar]
- 2. Orr TSC, Pollard MC, Gwilliam J, Cox JSG. Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using ‘double sensitization’ with two antigenically distinct rat reagins. Clin Exp Immunol 1970;7:745–57. [PMC free article] [PubMed] [Google Scholar]
- 3. Chung JTN, Jones BS. Bronchodilator effect of sodium cromoglycate and its clinical implications. BMJ 1979; 2: 1033–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Dixon M, Jackson DM, Richards IM. The action of sodium cromoglycate on ‘C’ fibre endings in the dog lung. Br J Pharmacol 1980; 3:180–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Jackson DM, Richards IM. The effects of sodium cromoglycate on histamine reflex bronchoconstriction in the anaesthetised dog. Br J Pharmacol 1977; 61:257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Altounyan REC. Changes in histamine and atropine responsiveness as a guide to diagnosis and evaluation of therapy in obstructive airways disease In: Disodium Cromoglycate in Allergic Airways Disease (Pepys J. & Frankland AW. eds), Butterworths, London , 1970: 47–53. [Google Scholar]
- 7. Callow KA, Tyrell DAJ, Shaw RJ, Fitzharris P, Wardlaw AJ, Kay AB. Influence of atopy on the clinical manifestations of coronovirus infections in adult volunteers. Clin Allergy 1988; 18:119–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Eggleston PA, Hendley JO, Gwaltney JM Jr. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infections. Ada Otolaryngol 1984; 413, (Suppl): 23–35. [DOI] [PubMed] [Google Scholar]
- 9. Balfour‐Lynn IM, Valman HB, Wellings R et al. Tumour necrosis faetor‐α and leukotriene E4 production in wheezy infants. Clin Exp Allergy 1994; 24:121–6. [DOI] [PubMed] [Google Scholar]
- 10. Bissonette EY, Befus AD. Modulation of mast cell function in the gastrointestinal tract In: Immunopharmacology of the gastrointestinal system. Academic Press, London . 1993: 95–103. [Google Scholar]
- 11. Staunton DE, Merluzze VJ, Rohlein R et al. A cell adhesion molecule, ICAM‐1, is the major surface receptor for rhinoviruses. Cell 1989; 56:848–53. [DOI] [PubMed] [Google Scholar]
- 12. Wegner CD, Gundel RH, Reilly P, Hynes N, Letts G, Rothlein R. Intercellular adhesion molecule (ICAM‐1) in the pathogenesis of asthma. Science 1990; 247:456–9. [DOI] [PubMed] [Google Scholar]
- 13. Duslin ML, Singer KH, Tuek DT, Springer TA. Adhesion of T lymphocytes to epidermal keratinocytes is regulated by IFNγ and is mediated by ICAM‐1. J Exp Med 1988; 167: 1323–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Penttineen K, Aarnio A, Hove T. Disodium cromoglycate can inhibit virus‐induced cytopatic effects in vitro. BMJ 1977; 1:82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Loveday D, Wenham RBM. Effect of disodium cromoglycate on virus‐celt system in vitro. BMJ 1977; 2:557–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Orr TSC. Nedocromil sodium: a new therapeutic option for reversible obstructive airways disease. Br J Clin Pract 1987; 41(11 Suppl): 9–12. [PubMed] [Google Scholar]
- 17. Barrow GL, Higgins PG, Al‐Nakib W, Smith AP, Wenham RBM, Tyrell DAJ. The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers. Clin Exp Allergy 1990; 20:45–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Del Mar C. Managing upper viral respiratory infections. Austr Fam Phys 1990; 20:557–61. [PubMed] [Google Scholar]
- 19. Al‐Nakib W, Higgins PG, Barrow G et al. Suppression of colds in human volunteers challenged wilh rhinovirus by a new synthetic drug (R61837). Antimicrobial Agents and Chemotherapy 1989; 33:522–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Gwaltney JM. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis 1992; 166:776–82. [DOI] [PubMed] [Google Scholar]
- 21. Hayden FG, Gwaltney JM, Colonno RJ. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res 1988; 9:233–47. [DOI] [PubMed] [Google Scholar]